The stock's valuation is now a proxy for the RAIN token price and the RAIN Option's Black-Scholes value, not Enlivex's clinical pipeline. Monitor RAIN token liquidity and exchange listings (KuCoin, WhiteBIT, Kraken) as the primary price driver, and watch for any further Lind note conversions that could dilute common shares. The termination of the $400M Rain Foundation PIPE removes a large overhang but also a potential capital source.
Price Chart
Executive Summary
Enlivex reported H1 2026 net income of $1.95B driven entirely by non-cash, unrealized gains on its RAIN digital asset holdings ($609.8M) and the RAIN purchase option ($1.94B), while its core clinical operations generated an operating loss of $15.8M and zero revenue. The company's balance sheet is dominated by digital assets ($1.25B in RAIN tokens) and the RAIN Option ($3.63B), with a $970M deferred tax liability. A subsequent amendment to the Lind convertible note increased principal to ~$19.2M, reduced monthly payments, and added a 10% interest trigger when market cap is below $75M, while a $400M private placement with The Rain Foundation was terminated in September 2026.
Key Facts
- H1 2026 net income of $1.95B vs. net loss of $5.3M in H1 2025; operating loss widened to $15.8M from $6.6M
- Revenue remains zero; all reported income is from non-cash unrealized gains on RAIN tokens ($609.8M) and the RAIN Option ($1.94B)
- Cash and cash equivalents only $5.5M; working capital of ~$3.7B is almost entirely illiquid digital assets and derivative
- RAIN token holdings: 79.6B tokens at fair value of $1.25B; RAIN Option fair value $3.63B (Level 2 derivative)
- Deferred tax liability of $970M on unrealized digital asset gains; effective tax rate 23%
- Lind convertible note amended Aug 2026: principal increased to ~$19.2M, monthly payments reduced to ~$1.2M, 10% interest accrues when market cap <$75M
- $400M private placement with The Rain Foundation terminated September 22, 2026
- 1-for-15 reverse stock split effective July 9, 2026; Nasdaq compliance regained July 23, 2026
- R&D expenses rose 41% to $6.6M; G&A surged 387% to $9.2M, largely from $6.2M in equity awards
Financial Impact
H1 2026 net income of $1.95B is entirely non-cash; operating cash burn of $10.9M; cash balance $5.5M
Risk Factors
- Extreme concentration risk: ~99% of total assets are in a single illiquid digital asset (RAIN) and a related derivative
- RAIN token price volatility could cause massive swings in reported earnings and equity; a 50% drop would eliminate ~$2.4B of asset value
- Deferred tax liability of $970M becomes payable in cash if digital assets are sold at gains
- Lind convertible note has aggressive conversion terms (80% of 3-lowest VWAPs) and a market-cap-based interest trigger that could accelerate dilution or cash demands
- Core business has zero revenue, widening operating losses, and only $5.5M cash — clinical development depends entirely on digital asset liquidity
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-103516 |
| Document: ea0306494-6k_enlivex.htm | 0001213900-26-103516 |
| Document: ea030649401ex99-2.htm | 0001213900-26-103516 |
| Document: 0001213900-26-103516-index-headers.html | 0001213900-26-103516 |
| Document: 0001213900-26-103516-index.html | 0001213900-26-103516 |
| Document: 0001213900-26-103516.txt | 0001213900-26-103516 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $0.1734 | awaiting T+5 | — | $2.56 (+1379.12%) |
Oct 22, 2026 4d ago | Press Release | $0.1734 | awaiting T+5 | — | $2.56 (+1379.12%) |
Oct 19, 2026 7d ago | 6-K | $0.2070 $0.1704 | ▲ +17.68% | ▲ +17.54% | $2.56 (−1139.03%) |
Oct 19, 2026 7d ago | Press Release | $0.2070 $0.1704 | ▲ +17.68% | ▲ +17.54% | $2.56 (−1139.03%) |
Sep 25, 2026 4w ago | 6-K | $0.5140 $0.3620 | ▼ −29.57% | ▼ −30.78% | $2.56 (+398.99%) |
Sep 22, 2026 4w ago | 6-K | $0.6464 $0.4801 | ▼ −25.73% | ▼ −24.54% | $2.56 (+296.78%) |
Aug 14, 2026 10w ago | EFFECT | $1.58 $1.47 | ▼ −6.96% | ▼ −5.59% | $2.56 (+62.33%) |
Jul 30, 2026 12w ago | 6-K | $1.95 $1.98 | ▲ +1.54% | ▼ −2.08% | $2.56 (+31.53%) |
Jul 29, 2026 12w ago | 6-K | $2.25 $2.18 | ▼ −3.11% | ▼ −8.64% | $2.56 (+13.99%) |
Jul 28, 2026 12w ago | 6-K | $2.24 $2.17 | ▲ +3.13% | ▲ +5.39% | $2.56 (−14.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers